The latest prostate cancer news
New recommendations on genetic testing for prostate cancer
A key area impacting prostate cancer risk and treatment is germline genetic testing, which involves…
Browsing: Prostate Cancer
World leading Prostate Cancer Centre of Excellence opens at Peter Mac
Peter MacCallum Cancer Centre will today officially open a world-leading Centre of Excellence to accelerate…
Some types of prostate cancer may not be as aggressive as originally thought
Researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, analysed gene-expression patterns in the most…
Sugars could be the key to an earlier, more accurate test for prostate cancer
A new type of test that uses complex sugars to detect prostate cancer earlier and…
ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer
Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise…
ASCO 2020: Blood test predicts response to prostate cancer treatment
A new blood test can predict how well men with advanced prostate cancer will respond…
FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration (FDA) granted accelerated approval to rucaparib for patients with deleterious…
FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer
On May 19, 2020, the Food and Drug Administration approved olaparib for adult patients with…
Potentially treatable genetic mutations revealed in subset of prostate cancer patients
Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable…
Approval of olaparib offers men first gene-targeted medicine for prostate cancer
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the US…